Diastolic Dysfunction of Aging Is Independent of Myocardial Structure but Associated with Plasma Advanced Glycation End-Product Levels

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Campbell, Duncan J ^a,b   Somaratne, Jithendra B ^c   Jenkins, Alicia J ^b   Prior, David L ^b,c   Yii, Michael ^b,c   Kenny, James F ^c   Newcomb, Andrew E ^b,c   Schalkwijk, Casper G ^d   Black, Mary Jane ^e   Kelly, Darren J ^b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c University of Maastricht ^*  (Australia)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; N EPSILON(CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG;

A WAVE; ADULT; AGE DISTRIBUTION; AGED; AGING; ARTERIOLE; ARTICLE; BLOOD LEVEL; CAPILLARY DENSITY; CARBOHYDRATE ANALYSIS; CARBOHYDRATE BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CELL SIZE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DECELERATION; DIASTOLIC DYSFUNCTION; DIFFUSION; DISEASE ASSOCIATION; E WAVE; FIBROSING ALVEOLITIS; FLOW RATE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR FIBROSIS;

ADULT; AGED; AGING; BLOOD CHEMICAL ANALYSIS; COLLAGEN; CORONARY ARTERY DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMODYNAMICS; HUMANS; LYSINE; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, IMMUNOLOGIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84870010314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049813     Document Type: Article

References (58)

1. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA, (2005) Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112: 2254-2262.
2. Lakatta EG, Levy D, (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: A "set up" for vascular disease. Circulation 107: 139-146.
3. Lakatta EG, Levy D, (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 107: 346-354.
4. Hollingsworth KG, Blamire AM, Keavney BD, Macgowan GA, (2012) Left ventricular torsion, energetics, and diastolic function in normal human aging. Am J Physiol Heart Circ Physiol 302: H885-892.
5. Unverferth DV, Fetters JK, Unverferth BJ, Leier CV, Magorien RD, et al. (1983) Human myocardial histologic characteristics in congestive heart failure. Circulation 68: 1194-1200.
6. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, et al. (2004) Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 110: 1263-1268.
7. Kasner M, Westermann D, Lopez B, Gaub R, Escher F, et al. (2011) Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol 57: 977-985.
8. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, et al. (2008) Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 52: 1391-1398.
9. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, et al. (2006) Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113: 1966-1973.
10. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, et al. (1990) Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 67: 871-885.
11. Tomanek RJ, Aydelotte MR, Torry RJ, (1991) Remodeling of coronary vessels during aging in purebred beagles. Circ Res 69: 1068-1074.
12. Anversa P, Li P, Sonnenblick EH, Olivetti G, (1994) Effects of aging on quantitative structural properties of coronary vasculature and microvasculature in rats. Am J Physiol Heart Circ Physiol 267: H1062-1073.
13. Rakusan K, Poupa O, (1964) Capillaries and muscle fibres in the heart of old rats. Gerontologia 69: 107-112.
14. Hartog JW, Voors AA, Bakker SJ, Smit AJ, van Veldhuisen DJ, (2007) Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail 9: 1146-1155.
15. Tikellis C, Thomas MC, Harcourt BE, Coughlan MT, Pete J, et al. (2008) Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab 295: E323-330.
16. Hartog JW, Voors AA, Schalkwijk CG, Scheijen J, Smilde TD, et al. (2007) Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J 28: 2879-2885.
17. Semba RD, Bandinelli S, Sun K, Guralnik JM, Ferrucci L, (2009) Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults. J Am Geriatr Soc 57: 1874-1880.
18. Roberts JT, Wearn JT, (1941) Quantitative changes in the capillary-muscle relationship in human hearts during normal growth and hypertrophy. Am Heart J 21: 617-633.
19. Olivetti G, Melissari M, Capasso JM, Anversa P, (1991) Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68: 1560-1568.
20. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, et al. (1995) Gender differences and aging: effects on the human heart. J Am Coll Cardiol 26: 1068-1079.
21. Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, et al. (2011) Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease. Hypertension 57: 186-192.
22. Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, et al. (2011) Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol 10: 80.
23. Campbell DJ, Somaratne JB, Jenkins AJ, Prior DL, Yii M, et al. (2012) Reduced microvascular density in non-ischaemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. Int J Cardiol doi:10.1016/j.ijcard.2012.03.075.
24. Alberti KG, Zimmet P, Shaw J, (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23: 469-480.
25. Zhu S, Heshka S, Wang Z, Shen W, Allison DB, et al. (2004) Combination of BMI and Waist Circumference for Identifying Cardiovascular Risk Factors in Whites. Obes Res 12: 633-645.
26. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26Suppl 1: S5-S20.
27. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, et al. (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17: 1086-1119.
28. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458.
29. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20: 1251-1260.
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
31. Wallace TM, Levy JC, Matthews DR, (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495.
32. Januszewski AS, Thomas MC, Chung SJ, Karschimkus CS, Rowley KG, et al. (2005) Plasma low-molecular weight fluorescence in type 1 diabetes mellitus. Ann NY Acad Sci 1043: 655-661.
33. Tomita H, Egashira K, Ohara Y, Takemoto M, Koyanagi M, et al. (1998) Early induction of transforming growth factor-ß via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 32: 273-279.
34. Gordon H, Sweets HH, (1936) A simple method for the silver impregnation of reticulin. Am J Pathol 12: 545-552.
35. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, et al. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394.
36. Tang Y, Nyengaard JR, Andersen JB, Baandrup U, Gundersen HJ, (2009) The application of stereological methods for estimating structural parameters in the human heart. Anat Rec (Hoboken) 292: 1630-1647.
37. Black MJ, Bertram JF, Johnston CI, (2001) Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat. J Hypertens 19: 785-794.
38. Lim K, Zimanyi MA, Black MJ, (2006) Effect of maternal protein restriction in rats on cardiac fibrosis and capillarization in adulthood. Pediatr Res 60: 83-87.
39. Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW, (2004) Increased accumulation of the glycoxidation product Nε-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta 1636: 82-89.
40. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, et al. (2011) Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 306: 856-863.
41. Kitzman DW, Sheikh KH, Beere PA, Philips JL, Higginbotham MB, (1991) Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 18: 1243-1250.
42. Prasad A, Okazaki K, Arbab-Zadeh A, Dijk E, Fu Q, et al. (2005) Abnormalities of Doppler measures of diastolic function in the healthy elderly are not related to alterations of left atrial pressure. Circulation 111: 1499-1503.
43. Yamakado T, Takagi E, Okubo S, Imanaka-Yoshida K, Tarumi T, et al. (1997) Effects of aging on left ventricular relaxation in humans. Analysis of left ventricular isovolumic pressure decay. Circulation 95: 917-923.
44. Lakatta EG, (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 107: 490-497.
45. Perseghin G, De Cobelli F, Esposito A, Belloni E, Lattuada G, et al. (2009) Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training. Heart 95: 630-635.
46. Schocke MF, Metzler B, Wolf C, Steinboeck P, Kremser C, et al. (2003) Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging 21: 553-559.
47. Okada M, Mitsunami K, Inubushi T, Kinoshita M, (1998) Influence of aging or left ventricular hypertrophy on the human heart: contents of phosphorus metabolites measured by 31P MRS. Magn Reson Med 39: 772-782.
48. Kostler H, Landschutz W, Koeppe S, Seyfarth T, Lipke C, et al. (2006) Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magn Reson Med 56: 907-911.
49. Linke WA, (2008) Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 77: 637-648.
50. van Heerebeek L, Franssen CP, Hamdani N, Verheugt FW, Somsen GA, et al. (2012) Molecular and cellular basis for diastolic dysfunction. Curr Heart Fail Rep. Available: http://link.springer.com/article/10.1007%1002Fs11897-11012-10109-11895?LI=true. Accessed 7 October 2012.
51. Dai DF, Chen T, Johnson SC, Szeto H, Rabinovitch PS, (2012) Cardiac aging: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 16: 1492-1526.
52. Shapiro BP, Owan TE, Mohammed SF, Meyer DM, Mills LD, et al. (2008) Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines. Circulation 118: 1002-1010.
53. Semba RD, Najjar SS, Sun K, Lakatta EG, Ferrucci L, (2009) Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults. Am J Hypertens 22: 74-79.
54. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, et al. (2001) Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104: 1464-1470.
55. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, et al. (1995) Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 146: 688-694.
56. Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA, (2011) RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 121: 43-55.
57. Unverferth DV, Baker PB, Arn AR, Magorien RD, Fetters J, et al. (1986) Aging of the human myocardium: a histologic study based upon endomyocardial biopsy. Gerontology 32: 241-251.
58. Rentrop KP, Cohen M, Blanke H, Phillips RA, (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5: 587-592.